Meridian Bioscience's Q4 Revenues Jump 16 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cincinnati-based diagnostics firm Meridian Bioscience today reported fourth-quarter revenue growth of 16 percent, with sales increases reported for both its diagnostics and life sciences businesses.

Meridian reported total revenues of $41.3 million for the three-month period ended Sept. 30, compared to $35.5 million for the third quarter of 2010. It fell short of analysts' consensus estimate of $42.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.